RT Journal Article
SR Electronic
T1 Association of age-friendly communities with health and well-being among older adults: an ecological and multilevel analysis from the Japan Gerontological Evaluation Study
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.06.21.24309218
DO 10.1101/2024.06.21.24309218
A1 Noguchi, Taiji
A1 Fujihara, Satoko
A1 Ide, Kazushige
A1 Jeong, Seungwon
A1 Saito, Tami
A1 Kondo, Katsunori
A1 Ojima, Toshiyuki
YR 2024
UL http://medrxiv.org/content/early/2024/06/21/2024.06.21.24309218.abstract
AB We examined the association of age-friendly communities with health and well-being among older adults in Japan. Ecological and multilevel analyses of 71,824 older adults across 145 communities revealed that the community’s age-friendliness consistently showed associations with health and well-being. Age-friendly physical environments (accessibility to barrier-free outdoor spaces, buildings, and transportation resources) exhibited an inverse association with functional health deficits. Social engagement and communication (participation in community groups, volunteer engagement, and information use) were inversely associated with depressive symptoms. Social inclusion and dementia-friendliness (respect and inclusion for older adults and positive attitudes toward people with dementia) were positively associated with happiness. The community’s age-friendliness reflected well the multiple aspects of older adults’ health and well-being.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by Japan Society for the Promotion of Science (JSPS), KAKENHI Grant Numbers (21K17322, 24K20158). This study was also supported by the Research Funding for Longevity Sciences from the National Centre for Geriatrics and Gerontology (24-21). The JAGES is supported by MEXT (Ministry of Education, Culture, Sports, Science and Technology of Japan)-Supported Program for the Strategic Research Foundation at Private Universities (2009-2013), JSPS (Japan Society for the Promotion of Science) KAKENHI Grant Numbers (JP18390200, JP22330172, JP22390400, JP23243070, JP23590786, JP23790710, JP24390469, JP24530698, JP24683018, JP25253052, JP25870573, JP25870881, JP26285138, JP26882010, JP15H01972), Health Labour Sciences Research Grants (H22-ChojuShitei008, H24-JunkankiIppan007, H24-ChikyukiboIppan009, H24-ChojuWakate009, H25-KenkiWakate015, H25-ChojuIppan003, H26-IrryoShitei003 [Fukkou], H26-ChojuIppan006, H27-NinchisyouIppan001, H28-ChojuIppan002, H28-NinchishoIppan002, H30-KenkiIppan006, H30-JunkankitouIppan004), Japan Agency for Medical Research and Development (AMED) (JP17dk0110017, JP18dk0110027, JP18ls0110002, JP18le0110009, JP19dk0110034), the Research Funding for Longevity Sciences from the National Centre for Geriatrics and Gerontology (24-17, 24-23, 29-42, 30-22, 20-40, 21-17, 21-20), and the Open Innovation Platform with Enterprises, and Research Institute and Academia (OPEEA, JPMJOP1831) from the Japan Science and Technology Agency.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was reviewed and approved by the ethics committees on Human Subjects at the National Center for Geriatrics and Gerontology (No. 992) and Chiba University (No. 2493). The mailed questionnaire was accompanied by a study explanation; participants who returned the completed questionnaire were considered to have provided informed consent. All our procedures conformed to the Declaration of Helsinki.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesFor the JAGES, all inquiries are to be addressed to the data management committee via e-mail: dataadmin.ml{at}jages.net. All JAGES datasets have ethical or legal restrictions for public deposition because of the inclusion of sensitive information about the human participants.